Americord Registry - Cord Blood Banking

Description

• Americord is a leader in the advancement of umbilical cord blood, cord tissue, and placenta tissue banking. As a private bank, Americord collects, processes, and stores newborn stem cells for future medical or therapeutic use by the family that saves them.Americord is committed to pioneering the development of new cord blood banking technologies. Under the direction of its Executive Medical Director, Dr. Robert Dracker, the company developed Cord Blood 2.0, which uses the companys proprietary Gravity Stand combined with a proprietary extraction process to harvest up to twice as many stem cells compared to a traditional cord blood collection. Dr. Dracker is also leading the development of CordAdvantage, which will apply even more advanced techniques to maximize the amount of stem cells that can be harvested from cord blood in the placenta and the umbilical cord.Based in New York, Americord is registered with the FDA and operates in all 50 states. The companys laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses.Our PromisesThe highest QUALITY stem cell banking products and services in the industryA proven commitment to pioneering INNOVATIONS that help families today and tomorrowThe most VALUE for your investment in cutting-edge medical options for your child and family
• 

  Headquarters:225 Broadway , New York, New York, United States

  More
• 

  Phone Number: +1 866-503-6005

• 

  Website: https://www.americordblood.com

• 

  Employees:30

• 

  Revenue:$10 - 50M

• 

  Legal Name:Americord Registry - Cord Blood Banking

• Americord Registry - Cord Blood Banking's Social Media

  
• Is this data correct?

• |  NAICS Code: 621999  |

  Show More